Diabetes

Early diagnosis and treatment can help manage the disease and improve quality of life for affected patients.

Valerie J. Parker, DVM, DACVIM (SAIM, Nutrition), talked all about body condition score, muscle condition score, and obesity prevention during a lecture at the Fetch Long Beach conference

Vicky Ograin, MBA, RVT, VTS, explained the types of foods that appeal to pets and offered tips for making food more palatable to these animals in a Fetch dvm360 Conference lecture

A team at Texas A&M University is using pig skin cells to explore the use of photodynamic therapy to treat melanoma in humans and animals

Renee Rucinsky, DVM, DABVP, discussed insulin therapy and SGLT2 inhibitors in her lecture at the Fetch dvm360 conference in Atlantic City

Christopher G. Byers, DVM, DACVECC, DACVIM (SAIM), CVJ, explains how Sodium-Glucose Cotransporter 2 Inhibitors are used to manage diabetes mellitus in cats

Each article highlights different advancements in the world of veterinary diabetes treatment and management

Education materials and starter kits to help clients manage diabetes in their pets are accessible through the Diabetes PetCare Alliance

Alex Sigmund, DVM, DACVO, discusses health issues that topical steroids and an antiglaucoma therapy can cause, ahead of his lecture at Fetch Kansas City

Dechra Limited has purchased Akston Biosciences’ developmental therapies for cats and dogs with diabetes

How new medications on the market are improving the lives of cats and pet owners.

Therapeutic success can be maximized through dietary modifications

A new peer-reviewed paper published in BMC Veterinary Research shows the potential veterinary use of weight loss drug implant

Trupanion analyzed over 20 years’ worth of data to identify common concerns for cats

Nationwide reveals the most common reason pets sought out veterinary care in 2023

An overview of this life-threatening condition will help guide veterinary practitioners

The program is expected to discuss a new oral hypoglycaemic agent (SGLT2-inhibitor) for management of feline diabetes

The Akston Biosciences technology is used to design therapies for humans and animals with diabetes

A recent study investigates therapeutic strategies for dogs with the disease that may also benefit humans with diabetes

We have compiled a countdown of our top 15 articles in 2023, here is number 15

Check out this week’s headlines

Jessica Pritchard, VMD, MS, DACVIM (SAIM), discusses how to talk with clients about diabetes

Jessica Pritchard, VMD, MS, DACVIM (SAIM), comments on how new treatments can make feline diabetes management easier

Jessica Pritchard, VMD, MS, DACVIM (SAIM), shares her opinion on the biggest challenge of pet diabetes and how Type 2 diabetes can be prevented

A novel class of drugs normalizes blood glucose in type 2 diabetic cats by dumping sugar into urine rather than modulating glucose uptake in the tissues but patient selection and close monitoring are crucial to using them safely

Jessica Pritchard, VMD, MS, DACVIM (SAIM), discusses the difference between Type 1 and Type 2 diabetes and how it differs in dogs and cats

A discussion on the traditional treatments for feline diabetes, with an introduction to some newer options coming to the market

Fetch Coastal lecturer Liza Wysong, BAS, RVT, VTS (CP-CF, SAIM), describes the discrepancies of this disease in dog and cat patients and the importance of an individualized approach

Akston Biosciences Corporation is working to development drugs to treat diabetes in pets as well as chronic pain in dogs and canine cancers

SENVELGO is a once daily medication to improve glycemic control in cats with diabetes mellitus